Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

Have a look at last year's conference agenda ...

Day 1

eyeforpharma Barcelona Day 1 - Morning

Keynotes
08:40 - 08:50
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

08:50 - 09:15
Redefining our role in a Volatile, Uncertain, Complex and Ambiguous (VUCA) world
  • Identify the challenges pharma must overcome in this world of unpredictable social, economic and political change
  • Be the solution: redefine the role we play in the healthcare eco-system and come together to build the solutions that truly meet the need of patients and care givers
  • Recognise how other industries have been disrupted by unexpected competition and ensure pharma is prepared to face the challenges of tomorrow
  • Explore the world of healthcare from a higher perspective and ensure that we are at the core of the discussion on the shape of its future

Janssen Kris Sterkens Company Group Chairman Europe, Middle East, and Africa Janssen

09:15 - 09:35
Creating greater value for patients in a shifting innovation paradigm
  • Bayer’s mission “Science For A Better Life” gives us purpose. For us the Pharma business means delivering superior value to all our stakeholders. But it is the patients that matter most.
  • Innovation is crucial in our journey to help patients. We are living in a revolutionary time of scientific change, particularly in medicine.
  • Unfortunately, interest in healthcare does not always equate to interest in better healthcare, as we are often faced with policy approaches targeting medicines’ budgets in isolation for the sake of short-term savings.
  • At the same time, at Bayer we recognize a shift in the innovation paradigm driven by digitization, increasing personalization and a resulting empowerment of the patient in the management of his / her own health. Such changes will give rise to new business models and new forms of value creation.

Bayer Pharmaceuticals Sebastian Guth Executive Vice President and Chief Marketing Officer Bayer Pharmaceuticals

09:35 - 09:55
Make the Future Personal
  • Join Christi in her personal mission to increase survival and quality of life for patients
  • Create new solutions guaranteeing more patents have access to life changing medicines
  • Technology tools is giving patients control and will improve our ability to provide personalized patient therapies
  • A new paradigm: collaboration with multiple stakeholders will be key to accelerating innovation and achieving better patient outcomes
  • Think beyond the medicine to focus on breakthroughs that come closer to a cure, and look towards a more holistic patient journey

Lilly Bio Medicines Christi Shaw Senior Vice President and President Lilly Bio Medicines

09:55 - 10:35
Panel: Futureproof patient access by delivering real value
  • How pharma can continue to deliver innovative medicines and maintain commercial success
  • Define the true value of your medicines and ensure this can be communicated to different stakeholders
  • How will the industry continue to deliver affordable treatments across challenging markets?

AstraZeneca Mark Mallon Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs AstraZeneca

Citi Andrew Baum Managing Director Global Head of Healthcare Research Citi

World Heart Federation Jean-Luc Eiselé CEO World Heart Federation

10:35 - 10:45
Winner announced eyeforpharma Awards - Most Valuable Patient Initiative
10:45 - 11:15
Coffee Break and Networking
11:15 - 11:55
Panel: Be the go-to source: how your company can become the ultimate guide for customers and patients
  • Can a pharma company become a credible hub for medical and product knowledge?
  • How the patient provides an aligning force between stakeholders – and how to use this to forge deeper partnerships
  • Beyond transparency: ideas for restoration of our industry’s reputation and regaining stakeholder trust in the information we provide
  • How advances in data capture and analysis can be harnessed to bolster relationships with key stakeholders

MSD Julie Gerberding Executive Vice President & Chief Patient Officer MSD

EFPIA Nathalie Moll Director General EFPIA

Gates Foundation Andrin Oswald Director – Life Sciences Partnerships,Global Health Gates Foundation

Merck Steven Hildemann Global Chief Medical Officer Merck KGaA

11:55 - 12:25
Hitting a smaller target, more often: driving profitable growth in a world of increasingly precise medicines
  • The Pharma industry continues to innovate at an increasingly faster pace, however, this innovation looks different today than it did 20 years ago with transformation from mass-market launches to the world of more targeted and precise medicine
  • A more precise world means new novel treatments in underserved diseases, higher survival rates and better outcomes for the patient and healthcare system
  • For pharma, it means patients and their prescribers are harder to find, competition is more intense and proving value of medicine is much harder.
  • To grow profitably, companies need to be more precise, targeted and efficient in developing and commercialising new innovations which will require leverage of the growing availability of healthcare data, advanced analytics and technology alongside innovations in human science

IQVIA Alistair Grenfell President North Europe, Middle East and Africa IQVIA

12:25 - 12:35
Winner announced eyeforpharma Awards - Patient Advocate Award
12:35 - 12:55
Beyond Producing Medicines: Advancing Access to Care is Part of Our Promise
  • Access is an Imperative, Not an Afterthought - understand how to steer this mindset across the whole organization
  • Patient Focus & Engagement are Critical - learn how to master this imperative in changing environments and among differing market trends
  • Proving Value Includes Quantifying It – how to focus on outcomes

CSL Limited Paul Perreault CEO CSL Limited

12:55 - 14:15
Lunch & Networking Session

eyeforpharma Medical Affairs Day 1 - Afternoon

14:15 - 14:20
Chairman Opening

Veeva Systems Sital Kotecha Director, Medical Strategy Veeva Systems

14:20 – 14:45
The evolution of Medical as the mission-critical function
  • Embrace the medical solution for your company’s vision of the future
  • See the value of your medical contributions to global strategic decisions
  • Identify where medical leadership can bring added value to your company

AstraZeneca Mark Mallon Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs AstraZeneca

14:45 – 15:15
Harness the Power of Technology & Data to Better Equip the New Medical Affairs Organization
  • Map your future with expert data analysis to identify current trends and actionable insights
  • Embrace the potential of AI and VR for competitive advantage
  • Leverage emerging technologies for a personalized learning experience

Medscape Jamie DeMaria Senior Vice President Medscape Education

15:15 – 16:20
Workshop by Complete HealthVizion

Thinking Smarter: Multichannel Communications and Behavioural Science, The Perfect Partners for Smarter Communications

16:20 - 16:50
Coffee Break & Networking Sessions
16:50 – 17:20
Rethinking evidence spend in late phase
  • The era of “precision medicine” has many implications for evidence development. The economics of the market dictate that if medicines are serving smaller patient populations, biopharmaceutical companies must support products and spend research dollars more efficiently.
  • A new array of design options and existing data sources provide expanded opportunities for design, endpoint and operational choices that provide cost efficiencies over traditional designs.
  • In this presentation, we will discuss a case study where a systemic review of late phase studies identified missed opportunities for design and operational efficiencies.

IQVIA Barbara Isquith Arone Vice President, Business Operations Center for Advanced Evidence Generation IQVIA

17:20 – 17:45
The Perfect Storm: the external winds of change propelling Medical to the forefront of business strategy
  • How medical can spearhead the response to value-based customer decisions
  • Offer the scientific depth, which other functions cannot, to satisfy payer demands for knowledge
  • Align your medical team with the requirements of regulators that can only be satisfied through medical leadership

Sanofi Antonio Tataranni Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit Sanofi

17:45 – 18:25
PANEL: Move past the metrics: ensure your primary objective is driving external value through business ownership
  • How to change the Medical culture to one of business ownership where metrics are the means to driving external value, not the objective
  • Improve customer experience and gain internal recognition as a bi-product of bringing external value
  • Where do we go from here? How can Medical evolve as the strategic partner to internal functions, while maintaining its role as the scientific partner of the customer

Merck Thomas D’Hooghe Vice-President and Head Global Medical Affairs Fertility Merck

Sanofi Hubert Bland UK Country Medical Chair and Medical Head Diabetes and Cardiovascular Sanofi

Bristol-Myers Squibb Ludovic Hacopian Worldwide Field Medical & Medical Effectiveness Bristol-Myers Squibb

Amgen Emma Booth Europe Medical Strategic Planning & Operations Amgen

Moderator: Speaker Logo Sital Kotecha Director, Medical Strategy Veeva Systems

18:25 - 20:00
Networking Drinks Reception

Day 2

eyeforpharma Medical Affairs Day 2

8:50 – 9:00
Chairman Opening

Complete HealthVizion Charlotte Moseley Global Head Complete HealthVizion

9:00 – 9:30
Maintain your external authenticity as your internal importance increases
  • Fuse your new strategic role with the scientific base that has already incurred increasing Medical influence
  • Bring together internal functions and destroy silos to devise strategy that is in the best interests of the patient
  • Evolve medical through increased external interaction and improve the image of pharma as a consequence

Ipsen Monica de Abadal Vice President Global Medical Affairs Services Ipsen

9:30 – 10:00
Promoting the patient voice in evidence generation and global market access planning
  • Overview of real-world challenges and considerations for use
  • Regulator and payer perspectives on patient-centric data in decision-making
  • Highly successful strategies for leveraging the patient voice in RWE research

PAREXEL Janice Haigh VP Pricing & Market Access PAREXEL

PAREXEL Kim Maguire-Wright Senior Solutions Consultant, Real World Evidence Solutions PAREXEL

10:00 – 10:40
PANEL: Continue to build trust between pharma and physicians through evidence based interactions
  • Keep your MSLs on-message in off-label discussions to collect core insights from wide ranging discussions
  • Teach your MSLs how to create open and frank dialogues with KOLs and HCPs that will lead to the most productive conversations
  • Gain a strategic advantage before market access by discussing drugs in clinical phases to understand what the market needs

Teva Kumaran Krishnan Associate Director MSL and Digital Transformation Teva

Takeda Gundula Schneidewind Managing Director Belgium Takeda

Roche James Mawby Head of Medical Affairs Roche

Moderator: Speaker Logo Hubert Bland Country Medical Chair and Medical Head Diabetes and Cardiovascular Sanofi UK

10:40 - 11:10
Coffee Break & Networking Sessions
11:10 – 11:40
The “value” of Medical Affairs to the medical community
  • Create a ‘value-added service’ for physicians through exclusively medical activities
  • Bring value to both customers and clinicians though enhanced communication processes
  • Build valuable partnerships where medical can have a leading role in the long term

Celgene Pam Bacon Executive Director Medical Affairs Celgene

11:40 – 12:10
Use digital to bring you closer to external stakeholders with data collection and dissemination
  • Gather real-time patient data for the most reliable study results
  • Communicate your data to HCPs and KOLs most effectively for maximum external engagement
  • Use digital platforms to share patient data with your colleagues in a compliant way

medcrowd Felix Jackson Founder medcrowd

12:10 – 13:15
ROUNDTABLE DISCUSSIONS
  1. What are the skills and expertise needed to face new Med Affairs objectives and challenges?
  2. How to best communicate your data to external stakeholders and gain insights in return
  3. What does AI offer Medical in the future?Led by experts from Medscape
  4. How to maintain MSL authenticity under commercial pressuresLed by experts from Spirit Medical Communications
13:15 - 14:15
Lunch & Networking Session
14:15 – 14:20
Chairman Opening

Complete HealthVizion Ian Greenway Medical Affairs Director Complete HealthVizion

14:20 – 14:50
A pinch of strategy: perfecting the recipe for success in Medical Affairs
  • The revolution in our kitchen – The changing landscape of Medical Affairs
  • Introducing new ingredients – A new blend of responsibility for Medical Affairs leaders
  • Prepare, mix, bake – Using the right approach to create an effective and affective Medical Affairs plan
  • Serving suggestions – How powerful communications can change patients’ lives

Complete HealthVizion Charlotte Moseley Global Head Complete HealthVizion

Complete HealthVizion Ian Greenway Medical Affairs Director Complete HealthVizion

14:50 – 15:20
Medical Affairs and innovation: writing the customer centric multichannel roadmap to lead other functions
  • Experience counts: why direct work with customers during the drug development period best equips Medical Affairs to understand customers centric solutions
  • Innovation defies ownership: why medical needs to step up and develop its own brand of innovation and solution development
  • Founded in Science: Why medical’s background is the key to developing a scientific narrative to feed content and lead all other functions

Eli Lilly Eduardo Elorz Former Oncology Global Medical Affairs Director Eli Lilly

15:20 – 15:50
The future of Real-World Evidence: optimising outcomes
  • Responding to a regulatory model that will gain earlier approval with less data from phase 3
  • Use real-world data to plan your route to a value-based healthcare system
  • Be more efficient in your research studies

Janssen Mike Spencer Head of RWE, EMEA Janssen

15:50 - 16:20
Coffee Break & Networking Sessions
16:20 – 16:50
Turn your MSLs into Medical Science Leaders
  • Identify the best candidates when recruiting the external faces of your brand
  • Upgrade your MSL team with developed business skills to complement their medical knowledge
  • See how a leading medical company have developed their MSL Centre of Excellence to instil a culture of quality

Shire Martina Muttke Group Vice President, Head of International Medical Affairs Shire

16:50 – 17:20
Own the Medical Narrative and drive partnership
  • Understand the evolution of measures of Field Medical value; from counting calls to unlocking the true value of MSL relations through qualitative methods
  • Create a cohesive framework that inspires your MSLs to deliver on global visions through differing, country dependent methods
  • Elevate the status of field medical from resource to strategic partner.

Bristol-Myers Squibb Victoria Ho Worldwide Field Medical & Communications Lead Bristol-Myers Squibb

17:20 – 17:50
Think Globally, Act Locally: Build your big picture one pixel at a time
  • Develop a Medical team that can understand their role in the global vision of the company
  • Give your team freedom to act depending on local issues to be most effective in their region
  • Align your team as a strategic partner from top to bottom to become a true mission-critical function

Sanofi Sandra Silvestri Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit, Sanofi

17:50 - 19:30
Networking Drinks Reception

Day 3

eyeforpharma Barcelona Day 3

Closing Keynote
08:55 - 09:00
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

09:00 - 09:30
Paving the way for the next generation of fully integrated care
  • Beyond medicine: Develop solutions that can deliver value and real benefits to patients' lives throughout the care continuum
  • Explore partnerships needed to provide holistic care and further support patients: the role that the industry can play
  • Understand the potential of digital in the development of future healthcare models and further possibilities on the horizon

Takeda Giles Platford President, Europe and Canada Business Unit Takeda

09:30 - 09:55
Paradigm shift: From selling drugs to bringing solutions to patients

AstraZeneca Bahija Jallal EVP & Head Medimmune AstraZeneca

09:55 - 10:25
From surviving to thriving: 4 steps to business optimisation
  • Understand why your sales department is the most critical tool for your future positioning and reputation
  • Examine four critical ways to prepare your sales organization for the future.
  • Uncover how to address the disruption in business to fix your sales organization before it’s too late.
  • Identify immediate steps required to improve your performance long-term

Miller Heiman Group Byron Matthews President and CEO Miller Heiman Group

10:25 - 10:35
Winner announced for the eyeforpharma Awards – Most Valuable HCP Initiative
10:35 - 11:15
Panel: The next step in truly integrated healthcare
  • The role of pharma in changing the delivery of healthcare and the partnerships required to solve genuine healthcare challenges
  • Develop a better understanding of the life and treatment with disease to deliver a seamless heathcare solution
  • How the digital revolution and information sharing will develop holistic intergrated care models

Novartis Shreeram Aradhye Chief Medical Officer, Global Head of Medical Affairs Novartis

UICC (Union for International Cancer Control) Dr. Cary Adams CEO UICC (Union for International Cancer Control)

Sanofi Colin Sims SVP, Head, Transversal Corporate Strategy Sanofi

11:15 - 11:45
Coffee Break & Networking Session in the Exhibition Hall
11:45 - 12:10
Decoding the future: democratising AI to empower better outcomes
  • Explore the role of systems of intelligence to reason over an ever-growing amount of health data to advance the promise of precision medicine, shorten and sharpen clinical trials
  • Discover new digital engagement models as companion services to enhance adherence, manage chronic conditions and prevent diseases
  • Trust and new governance models of health data as enabling conditions for future-proof innovation

Microsoft Elena Bonfiglioli Managing Director, Health & Life Science EMEA Microsoft

12:10 - 12:50
Digital Panel: Harness the true power of digital to perform strategic transformations that deliver genuine healthcare innovation
  • The role of digital in improving patient outcomes and commercial results
  • Ensure uptake of digital practices across the entire organisation and embed your digital strategy into the culture
  • The role digital innovations will play in the future of healthcare and how we can get there

Sanofi Milind Kamkolkar Chief Data Officer Sanofi

AstraZeneca Bahija Jallal EVP & Head of Medimmune AstraZeneca

Roche Diabetes Care Jacob Suñol Digital CTO & Digital Ecosystem Roche Diabetes Care

12:50 - 13:05
Winner announced for the eyeforpharma Awards – Most Valuable Collaboration & Lifetime Achievement Award
13:05 - 13:25
Almirall, a journey towards specialization

A journey through our strategic thinking. The reinvention of Almirall and the changes we have made to become a specialized dermatology company

Almirall Alfredo Barón de Juan EVP Global Commercial Operations Almirall

13:25 - 14:40
Seated Lunch & Networking Session on the 2nd Floor

Day 1

eyeforpharma Barcelona Day 1 - Morning

Keynotes
08:40 - 08:50
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

08:50 - 09:15
Redefining our role in a Volatile, Uncertain, Complex and Ambiguous (VUCA) world
  • Identify the challenges pharma must overcome in this world of unpredictable social, economic and political change
  • Be the solution: redefine the role we play in the healthcare eco-system and come together to build the solutions that truly meet the need of patients and care givers
  • Recognise how other industries have been disrupted by unexpected competition and ensure pharma is prepared to face the challenges of tomorrow
  • Explore the world of healthcare from a higher perspective and ensure that we are at the core of the discussion on the shape of its future

Janssen Kris Sterkens Company Group Chairman Europe, Middle East, and Africa Janssen

09:15 - 09:35
Creating greater value for patients in a shifting innovation paradigm
  • Bayer’s mission “Science For A Better Life” gives us purpose. For us the Pharma business means delivering superior value to all our stakeholders. But it is the patients that matter most.
  • Innovation is crucial in our journey to help patients. We are living in a revolutionary time of scientific change, particularly in medicine.
  • Unfortunately, interest in healthcare does not always equate to interest in better healthcare, as we are often faced with policy approaches targeting medicines’ budgets in isolation for the sake of short-term savings.
  • At the same time, at Bayer we recognize a shift in the innovation paradigm driven by digitization, increasing personalization and a resulting empowerment of the patient in the management of his / her own health. Such changes will give rise to new business models and new forms of value creation.

Bayer Pharmaceuticals Sebastian Guth Executive Vice President and Chief Marketing Officer Bayer Pharmaceuticals

09:35 - 09:55
Make the Future Personal
  • Join Christi in her personal mission to increase survival and quality of life for patients
  • Create new solutions guaranteeing more patents have access to life changing medicines
  • Technology tools is giving patients control and will improve our ability to provide personalized patient therapies
  • A new paradigm: collaboration with multiple stakeholders will be key to accelerating innovation and achieving better patient outcomes
  • Think beyond the medicine to focus on breakthroughs that come closer to a cure, and look towards a more holistic patient journey

Lilly Bio Medicines Christi Shaw Senior Vice President and President Lilly Bio Medicines

09:55 - 10:35
Panel: Futureproof patient access by delivering real value
  • How pharma can continue to deliver innovative medicines and maintain commercial success
  • Define the true value of your medicines and ensure this can be communicated to different stakeholders
  • How will the industry continue to deliver affordable treatments across challenging markets?

AstraZeneca Mark Mallon Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs AstraZeneca

Citi Andrew Baum Managing Director Global Head of Healthcare Research Citi

World Heart Federation Jean-Luc Eiselé CEO World Heart Federation

10:35 - 10:45
Winner announced eyeforpharma Awards - Most Valuable Patient Initiative
10:45 - 11:15
Coffee Break and Networking
11:15 - 11:55
Panel: Be the go-to source: how your company can become the ultimate guide for customers and patients
  • Can a pharma company become a credible hub for medical and product knowledge?
  • How the patient provides an aligning force between stakeholders – and how to use this to forge deeper partnerships
  • Beyond transparency: ideas for restoration of our industry’s reputation and regaining stakeholder trust in the information we provide
  • How advances in data capture and analysis can be harnessed to bolster relationships with key stakeholders

MSD Julie Gerberding Executive Vice President & Chief Patient Officer MSD

EFPIA Nathalie Moll Director General EFPIA

Gates Foundation Andrin Oswald Director – Life Sciences Partnerships,Global Health Gates Foundation

Merck Steven Hildemann Global Chief Medical Officer Merck KGaA

11:55 - 12:25
Hitting a smaller target, more often: driving profitable growth in a world of increasingly precise medicines
  • The Pharma industry continues to innovate at an increasingly faster pace, however, this innovation looks different today than it did 20 years ago with transformation from mass-market launches to the world of more targeted and precise medicine
  • A more precise world means new novel treatments in underserved diseases, higher survival rates and better outcomes for the patient and healthcare system
  • For pharma, it means patients and their prescribers are harder to find, competition is more intense and proving value of medicine is much harder.
  • To grow profitably, companies need to be more precise, targeted and efficient in developing and commercialising new innovations which will require leverage of the growing availability of healthcare data, advanced analytics and technology alongside innovations in human science

IQVIA Alistair Grenfell President North Europe, Middle East and Africa IQVIA

12:25 - 12:35
Winner announced eyeforpharma Awards - Patient Advocate Award
12:35 - 12:55
Beyond Producing Medicines: Advancing Access to Care is Part of Our Promise
  • Access is an Imperative, Not an Afterthought - understand how to steer this mindset across the whole organization
  • Patient Focus & Engagement are Critical - learn how to master this imperative in changing environments and among differing market trends
  • Proving Value Includes Quantifying It – how to focus on outcomes

CSL Limited Paul Perreault CEO CSL Limited

12:55 - 14:15
Lunch & Networking Session

eyeforpharma Medical Affairs Day 1 - Afternoon

14:15 - 14:20
Chairman Opening

Veeva Systems Sital Kotecha Director, Medical Strategy Veeva Systems

14:20 – 14:45
The evolution of Medical as the mission-critical function
  • Embrace the medical solution for your company’s vision of the future
  • See the value of your medical contributions to global strategic decisions
  • Identify where medical leadership can bring added value to your company

AstraZeneca Mark Mallon Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs AstraZeneca

14:45 – 15:15
Harness the Power of Technology & Data to Better Equip the New Medical Affairs Organization
  • Map your future with expert data analysis to identify current trends and actionable insights
  • Embrace the potential of AI and VR for competitive advantage
  • Leverage emerging technologies for a personalized learning experience

Medscape Jamie DeMaria Senior Vice President Medscape Education

15:15 – 16:20
Workshop by Complete HealthVizion

Thinking Smarter: Multichannel Communications and Behavioural Science, The Perfect Partners for Smarter Communications

16:20 - 16:50
Coffee Break & Networking Sessions
16:50 – 17:20
Rethinking evidence spend in late phase
  • The era of “precision medicine” has many implications for evidence development. The economics of the market dictate that if medicines are serving smaller patient populations, biopharmaceutical companies must support products and spend research dollars more efficiently.
  • A new array of design options and existing data sources provide expanded opportunities for design, endpoint and operational choices that provide cost efficiencies over traditional designs.
  • In this presentation, we will discuss a case study where a systemic review of late phase studies identified missed opportunities for design and operational efficiencies.

IQVIA Barbara Isquith Arone Vice President, Business Operations Center for Advanced Evidence Generation IQVIA

17:20 – 17:45
The Perfect Storm: the external winds of change propelling Medical to the forefront of business strategy
  • How medical can spearhead the response to value-based customer decisions
  • Offer the scientific depth, which other functions cannot, to satisfy payer demands for knowledge
  • Align your medical team with the requirements of regulators that can only be satisfied through medical leadership

Sanofi Antonio Tataranni Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit Sanofi

17:45 – 18:25
PANEL: Move past the metrics: ensure your primary objective is driving external value through business ownership
  • How to change the Medical culture to one of business ownership where metrics are the means to driving external value, not the objective
  • Improve customer experience and gain internal recognition as a bi-product of bringing external value
  • Where do we go from here? How can Medical evolve as the strategic partner to internal functions, while maintaining its role as the scientific partner of the customer

Merck Thomas D’Hooghe Vice-President and Head Global Medical Affairs Fertility Merck

Sanofi Hubert Bland UK Country Medical Chair and Medical Head Diabetes and Cardiovascular Sanofi

Bristol-Myers Squibb Ludovic Hacopian Worldwide Field Medical & Medical Effectiveness Bristol-Myers Squibb

Amgen Emma Booth Europe Medical Strategic Planning & Operations Amgen

Moderator: Speaker Logo Sital Kotecha Director, Medical Strategy Veeva Systems

18:25 - 20:00
Networking Drinks Reception

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Day 2

eyeforpharma Medical Affairs Day 2

8:50 – 9:00
Chairman Opening

Complete HealthVizion Charlotte Moseley Global Head Complete HealthVizion

9:00 – 9:30
Maintain your external authenticity as your internal importance increases
  • Fuse your new strategic role with the scientific base that has already incurred increasing Medical influence
  • Bring together internal functions and destroy silos to devise strategy that is in the best interests of the patient
  • Evolve medical through increased external interaction and improve the image of pharma as a consequence

Ipsen Monica de Abadal Vice President Global Medical Affairs Services Ipsen

9:30 – 10:00
Promoting the patient voice in evidence generation and global market access planning
  • Overview of real-world challenges and considerations for use
  • Regulator and payer perspectives on patient-centric data in decision-making
  • Highly successful strategies for leveraging the patient voice in RWE research

PAREXEL Janice Haigh VP Pricing & Market Access PAREXEL

PAREXEL Kim Maguire-Wright Senior Solutions Consultant, Real World Evidence Solutions PAREXEL

10:00 – 10:40
PANEL: Continue to build trust between pharma and physicians through evidence based interactions
  • Keep your MSLs on-message in off-label discussions to collect core insights from wide ranging discussions
  • Teach your MSLs how to create open and frank dialogues with KOLs and HCPs that will lead to the most productive conversations
  • Gain a strategic advantage before market access by discussing drugs in clinical phases to understand what the market needs

Teva Kumaran Krishnan Associate Director MSL and Digital Transformation Teva

Takeda Gundula Schneidewind Managing Director Belgium Takeda

Roche James Mawby Head of Medical Affairs Roche

Moderator: Speaker Logo Hubert Bland Country Medical Chair and Medical Head Diabetes and Cardiovascular Sanofi UK

10:40 - 11:10
Coffee Break & Networking Sessions
11:10 – 11:40
The “value” of Medical Affairs to the medical community
  • Create a ‘value-added service’ for physicians through exclusively medical activities
  • Bring value to both customers and clinicians though enhanced communication processes
  • Build valuable partnerships where medical can have a leading role in the long term

Celgene Pam Bacon Executive Director Medical Affairs Celgene

11:40 – 12:10
Use digital to bring you closer to external stakeholders with data collection and dissemination
  • Gather real-time patient data for the most reliable study results
  • Communicate your data to HCPs and KOLs most effectively for maximum external engagement
  • Use digital platforms to share patient data with your colleagues in a compliant way

medcrowd Felix Jackson Founder medcrowd

12:10 – 13:15
ROUNDTABLE DISCUSSIONS
  1. What are the skills and expertise needed to face new Med Affairs objectives and challenges?
  2. How to best communicate your data to external stakeholders and gain insights in return
  3. What does AI offer Medical in the future?Led by experts from Medscape
  4. How to maintain MSL authenticity under commercial pressuresLed by experts from Spirit Medical Communications
13:15 - 14:15
Lunch & Networking Session
14:15 – 14:20
Chairman Opening

Complete HealthVizion Ian Greenway Medical Affairs Director Complete HealthVizion

14:20 – 14:50
A pinch of strategy: perfecting the recipe for success in Medical Affairs
  • The revolution in our kitchen – The changing landscape of Medical Affairs
  • Introducing new ingredients – A new blend of responsibility for Medical Affairs leaders
  • Prepare, mix, bake – Using the right approach to create an effective and affective Medical Affairs plan
  • Serving suggestions – How powerful communications can change patients’ lives

Complete HealthVizion Charlotte Moseley Global Head Complete HealthVizion

Complete HealthVizion Ian Greenway Medical Affairs Director Complete HealthVizion

14:50 – 15:20
Medical Affairs and innovation: writing the customer centric multichannel roadmap to lead other functions
  • Experience counts: why direct work with customers during the drug development period best equips Medical Affairs to understand customers centric solutions
  • Innovation defies ownership: why medical needs to step up and develop its own brand of innovation and solution development
  • Founded in Science: Why medical’s background is the key to developing a scientific narrative to feed content and lead all other functions

Eli Lilly Eduardo Elorz Former Oncology Global Medical Affairs Director Eli Lilly

15:20 – 15:50
The future of Real-World Evidence: optimising outcomes
  • Responding to a regulatory model that will gain earlier approval with less data from phase 3
  • Use real-world data to plan your route to a value-based healthcare system
  • Be more efficient in your research studies

Janssen Mike Spencer Head of RWE, EMEA Janssen

15:50 - 16:20
Coffee Break & Networking Sessions
16:20 – 16:50
Turn your MSLs into Medical Science Leaders
  • Identify the best candidates when recruiting the external faces of your brand
  • Upgrade your MSL team with developed business skills to complement their medical knowledge
  • See how a leading medical company have developed their MSL Centre of Excellence to instil a culture of quality

Shire Martina Muttke Group Vice President, Head of International Medical Affairs Shire

16:50 – 17:20
Own the Medical Narrative and drive partnership
  • Understand the evolution of measures of Field Medical value; from counting calls to unlocking the true value of MSL relations through qualitative methods
  • Create a cohesive framework that inspires your MSLs to deliver on global visions through differing, country dependent methods
  • Elevate the status of field medical from resource to strategic partner.

Bristol-Myers Squibb Victoria Ho Worldwide Field Medical & Communications Lead Bristol-Myers Squibb

17:20 – 17:50
Think Globally, Act Locally: Build your big picture one pixel at a time
  • Develop a Medical team that can understand their role in the global vision of the company
  • Give your team freedom to act depending on local issues to be most effective in their region
  • Align your team as a strategic partner from top to bottom to become a true mission-critical function

Sanofi Sandra Silvestri Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit, Sanofi

17:50 - 19:30
Networking Drinks Reception

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Day 3

eyeforpharma Barcelona Day 3

Closing Keynote
08:55 - 09:00
Chairman Opening

eyeforpharma Paul Simms Chairman eyeforpharma

09:00 - 09:30
Paving the way for the next generation of fully integrated care
  • Beyond medicine: Develop solutions that can deliver value and real benefits to patients' lives throughout the care continuum
  • Explore partnerships needed to provide holistic care and further support patients: the role that the industry can play
  • Understand the potential of digital in the development of future healthcare models and further possibilities on the horizon

Takeda Giles Platford President, Europe and Canada Business Unit Takeda

09:30 - 09:55
Paradigm shift: From selling drugs to bringing solutions to patients

AstraZeneca Bahija Jallal EVP & Head Medimmune AstraZeneca

09:55 - 10:25
From surviving to thriving: 4 steps to business optimisation
  • Understand why your sales department is the most critical tool for your future positioning and reputation
  • Examine four critical ways to prepare your sales organization for the future.
  • Uncover how to address the disruption in business to fix your sales organization before it’s too late.
  • Identify immediate steps required to improve your performance long-term

Miller Heiman Group Byron Matthews President and CEO Miller Heiman Group

10:25 - 10:35
Winner announced for the eyeforpharma Awards – Most Valuable HCP Initiative
10:35 - 11:15
Panel: The next step in truly integrated healthcare
  • The role of pharma in changing the delivery of healthcare and the partnerships required to solve genuine healthcare challenges
  • Develop a better understanding of the life and treatment with disease to deliver a seamless heathcare solution
  • How the digital revolution and information sharing will develop holistic intergrated care models

Novartis Shreeram Aradhye Chief Medical Officer, Global Head of Medical Affairs Novartis

UICC (Union for International Cancer Control) Dr. Cary Adams CEO UICC (Union for International Cancer Control)

Sanofi Colin Sims SVP, Head, Transversal Corporate Strategy Sanofi

11:15 - 11:45
Coffee Break & Networking Session in the Exhibition Hall
11:45 - 12:10
Decoding the future: democratising AI to empower better outcomes
  • Explore the role of systems of intelligence to reason over an ever-growing amount of health data to advance the promise of precision medicine, shorten and sharpen clinical trials
  • Discover new digital engagement models as companion services to enhance adherence, manage chronic conditions and prevent diseases
  • Trust and new governance models of health data as enabling conditions for future-proof innovation

Microsoft Elena Bonfiglioli Managing Director, Health & Life Science EMEA Microsoft

12:10 - 12:50
Digital Panel: Harness the true power of digital to perform strategic transformations that deliver genuine healthcare innovation
  • The role of digital in improving patient outcomes and commercial results
  • Ensure uptake of digital practices across the entire organisation and embed your digital strategy into the culture
  • The role digital innovations will play in the future of healthcare and how we can get there

Sanofi Milind Kamkolkar Chief Data Officer Sanofi

AstraZeneca Bahija Jallal EVP & Head of Medimmune AstraZeneca

Roche Diabetes Care Jacob Suñol Digital CTO & Digital Ecosystem Roche Diabetes Care

12:50 - 13:05
Winner announced for the eyeforpharma Awards – Most Valuable Collaboration & Lifetime Achievement Award
13:05 - 13:25
Almirall, a journey towards specialization

A journey through our strategic thinking. The reinvention of Almirall and the changes we have made to become a specialized dermatology company

Almirall Alfredo Barón de Juan EVP Global Commercial Operations Almirall

13:25 - 14:40
Seated Lunch & Networking Session on the 2nd Floor

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription